✦ For YouGeopoliticsTechFinanceHealthEnergySportsCulture◆ SN Last Week★ Saved

Health·3,530 stories

Health News — Page 131

FDA Fast-Tracks Psychedelic Drugs From Compass, Usona

FDA Fast-Tracks Psychedelic Drugs From Compass, Usona

The FDA is fast-tracking psychedelic treatments from Compass Pathways, Usona Institute, and Transcend Therapeutics, granting priority review vouchers to boost access to psilocybin and MDMA-like drugs

STAT News · 5mo ago
Eli Lilly Buys Kelonia Therapeutics for $3.2B

Eli Lilly Buys Kelonia Therapeutics for $3.2B

Eli Lilly is buying cash‑strapped cell‑therapy developer Kelonia Therapeutics for $3.2 billion, a deal that could double with milestone payments. Partner Bryan Roberts of Venrock explains how the star

STAT News · 5mo ago
Tenpoint Therapeutics Appoints Stephen Lane as CMO

Tenpoint Therapeutics Appoints Stephen Lane as CMO

Tenpoint Therapeutics has hired Stephen Lane as its new chief medical officer, bringing his Alcon experience and leadership of the Holland Foundation for Sight Restoration to the company. The appointm

STAT News · 5mo ago
Trump Reclassifies Marijuana, FDA Fast‑Tracks Devices

Trump Reclassifies Marijuana, FDA Fast‑Tracks Devices

President Trump’s drug policy overhaul moves medical marijuana to Schedule III and opens doors for psychedelics research, while CMS and FDA roll out a fast‑track Medicare pathway for breakthrough devi

STAT News · 5mo ago
STAT+: Pharmalittle: We’re reading about a Trump deal with Regeneron, reclassifying medical marijuana, and more

STAT+: Pharmalittle: We’re reading about a Trump deal with Regeneron, reclassifying medical marijuana, and more

President Trump closed the White House’s 17‑deal pharma pricing push with Regeneron, locking in a $27 billion U.S. drug‑development investment and a $225 price for Praluent on TrumpRx. At the same tim

STAT News · 5mo ago
Sanofi MS Drug Receives EU Approval Recommendation

Sanofi MS Drug Receives EU Approval Recommendation

Amid ongoing legal battles for the Trump administration, biotech headlines dominate: Sanofi’s multiple sclerosis therapy, turned down by the FDA, earned a positive recommendation from European regulat

STAT News · 5mo ago
Personalized Plans Boost Dementia Cognition 13.7 Points in Trial

Personalized Plans Boost Dementia Cognition 13.7 Points in Trial

A nine-month trial of personalized treatment plans for 73 people with mild cognitive impairment or early-stage dementia found that participants who received bespoke medical and lifestyle interventions

New Scientist · 5mo ago
Hefford, Wilson unveil QBox post‑quantum theory

Hefford, Wilson unveil QBox post‑quantum theory

Physicists James Hefford and Matt Wilson have outlined a post‑quantum framework called QBox, where a hyperdecoherence process generates ordinary quantum mechanics while permitting causal indefinitenes

New Scientist · 5mo ago
First Human Trial of Partial Reprogramming Stem Cells

First Human Trial of Partial Reprogramming Stem Cells

After a string of costly anti‑aging flops—from resveratrol’s $720 million demise at GSK to failed senolytics—researchers are finally testing a new approach: transient expression of Yamanaka factors to

New Scientist · 5mo ago
EU's Largest-Ever Toxic Chemical Ban Stalled by 'Unlawful' Delays

EU's Largest-Ever Toxic Chemical Ban Stalled by 'Unlawful' Delays

Four years after the European Commission unveiled what was hailed as its largest-ever ban on toxic chemicals, a new report finds it has failed to begin regulating seven of 22 hazardous substance group

The Guardian Science · 5mo ago
Jerash Mass Grave Confirms Plague of Justinian Deaths

Jerash Mass Grave Confirms Plague of Justinian Deaths

A newly confirmed mass grave in Jerash, Jordan, shows that hundreds of people died within days during the Plague of Justinian, offering direct archaeological and genetic evidence of the pandemic’s rap

Science Daily · 5mo ago
A CAR-T biotech’s dramatic turnaround, and drugmakers’ tactics to drive more scripts

A CAR-T biotech’s dramatic turnaround, and drugmakers’ tactics to drive more scripts

After surviving three cash crises, CAR‑T pioneer Kelonia Therapeutics secured a $3.25 billion buyout by Eli Lilly, underscoring how high‑risk biotech turnarounds can translate into massive exits. At t

STAT News · 5mo ago
STAT+: Trump celebrates closing first round of drug pricing deals, promises more ahead

STAT+: Trump celebrates closing first round of drug pricing deals, promises more ahead

Amid mounting legal scrutiny and a foreign‑policy spotlight, Trump touts a domestic win: the final drug‑pricing pact with Regeneron, capping a series of 17 White House‑initiated deals. The agreement c

STAT News · 5mo ago
Heart Beat Stress Blocks Cancer in Mice

Heart Beat Stress Blocks Cancer in Mice

A mouse study led by researchers at the International Centre for Genetic Engineering and Biotechnology shows that the heart’s relentless beating creates mechanical stress that suppresses tumor growth,

STAT News · 5mo ago
STAT+: Trump’s boosting of psychedelics, cannabis signal a new era in GOP drug policy

STAT+: Trump’s boosting of psychedelics, cannabis signal a new era in GOP drug policy

Facing mounting legal scrutiny, President Trump shifted his agenda to drug policy, signing a $50 million executive order to fast‑track FDA approval of psychedelics and urging the DEA to lower marijuan

STAT News · 5mo ago
19-Metre Octopuses Crushed Prey in Cretaceous Seas

19-Metre Octopuses Crushed Prey in Cretaceous Seas

A new study in Science reveals that ancient octopus relatives up to 19 metres long used powerful, bone-crushing beaks to dominate Cretaceous oceans as apex predators who may have preyed on marine rept

The Guardian Science · 5mo ago
RSV Blocks Breast Cancer Lung Spread in Mouse Study

RSV Blocks Breast Cancer Lung Spread in Mouse Study

Mouse experiments show respiratory syncytial virus (RSV) triggers an immune response that reduces breast cancer cells seeding in the lungs by 65-70%, with researchers identifying type I interferons an

New Scientist · 5mo ago
Sanofi CEO Garijo Takes Helm Amid Immunology Results

Sanofi CEO Garijo Takes Helm Amid Immunology Results

Garijo steps in as Sanofi’s new CEO this month, inheriting a pipeline dominated by immunology after a series of lackluster trial outcomes. The biotech landscape also sees a gene‑therapy for deafness m

STAT News · 5mo ago
Yale Study Links EBV to Multiple Sclerosis

Yale Study Links EBV to Multiple Sclerosis

A new analysis of 617,186 participants from the UK Biobank and All of Us shows that Epstein‑Barr virus concentrates in B‑cells, hijacking them and triggering genes linked to multiple sclerosis. The wo

New Scientist · 5mo ago
Northwestern Finds 80-Year-Olds with 50-Year-Old Memory

Northwestern Finds 80-Year-Olds with 50-Year-Old Memory

Northwestern researchers have followed a cohort of 80‑year‑olds dubbed SuperAgers, whose memory rivals that of people 30 years younger. Brain scans reveal a distinct neurobiological profile that resis

Science Daily · 5mo ago

Get the Health newsletter

Curated health stories, every morning. Free.

No spam. Unsubscribe anytime.